InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
4
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by Mates Sharon, Chairman & CEO. Officer active across 1 company, notably Intra-Cellular Therapies, Inc.. In total, 26 filings have been logged. Breakdown: 0 buy · 4 sells. Total volume traded: €5.1m. History available since 23 August 2021. The latest transaction was disclosed on 2 April 2025 (Disposition). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Mates Sharon
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations26 total
945,235 shares@ US$132.0092.8% of flowCommon StockSEC:0000950170-25-049595:0
190,000 shares0Common StockSEC:0000950170-25-047937:0
40,712 sharesCommon StockSEC:0000950170-25-036593:0
34,969 sharesCommon StockSEC:0000950170-25-032587:0
30,847 shares0Common StockSEC:0000950170-25-013765:0
51,000 shares@ US$12.730.5% of flowCommon StockSEC:0000950170-24-134240:0
35,604 shares@ US$12.730.3% of flowCommon StockSEC:0000950170-24-102475:0
22,713 shares@ US$17.570.3% of flowCommon StockSEC:0000950170-24-101506:0
53,013 shares@ US$17.570.7% of flowCommon StockSEC:0000950170-24-100275:0
8,638 shares@ US$16.860.1% of flowCommon StockSEC:0000950170-24-048467:0
31,958 shares@ US$66.381.6% of flowCommon StockSEC:0000950170-24-029583:0
40,712 sharesCommon StockSEC:0000950170-24-028822:0
22,590 sharesCommon StockSEC:0000950170-24-021568:0
33,885 shares0Common StockSEC:0000950170-24-011398:0
75,361 shares@ US$16.860.9% of flowCommon StockSEC:0000950170-24-005557:0
27,468 shares@ US$53.5541.1% of flowCommon StockSEC:0001209191-23-050101:0
41,770 shares0Common StockSEC:0001209191-23-018283:0
22,590 sharesCommon StockSEC:0001209191-23-013434:0
27,848 sharesCommon StockSEC:0001209191-23-011982:0
33,083 shares@ US$55.001.4% of flowCommon StockSEC:0001209191-22-061532:0
38,925 shares@ US$2.840.1% of flowCommon StockSEC:0001209191-22-017858:0
22,589 sharesCommon StockSEC:0001209191-22-013346:0
27,847 sharesCommon StockSEC:0001209191-22-012385:0
41,896 sharesCommon StockSEC:0001209191-22-002984:0
1,416 shares@ US$40.000.0% of flowCommon StockSEC:0001209191-21-060741:0
25 of 26 declarations
About Mates Sharon
Mates Sharon is Président-Directeur Général at Intra-Cellular Therapies, Inc. The 26 filings recorded cover the period from 2021-08-24 to 2025-04-02, and, for the recent sampled filings held, the total sell amount is EUR 119474436, with the dominant transaction nature stated as Levée d'options.
